全文获取类型
收费全文 | 46199篇 |
免费 | 4940篇 |
国内免费 | 951篇 |
专业分类
耳鼻咽喉 | 323篇 |
儿科学 | 1011篇 |
妇产科学 | 620篇 |
基础医学 | 3605篇 |
口腔科学 | 1558篇 |
临床医学 | 4397篇 |
内科学 | 6331篇 |
皮肤病学 | 489篇 |
神经病学 | 3540篇 |
特种医学 | 1366篇 |
外国民族医学 | 3篇 |
外科学 | 3935篇 |
综合类 | 5084篇 |
现状与发展 | 5篇 |
一般理论 | 2篇 |
预防医学 | 7836篇 |
眼科学 | 592篇 |
药学 | 3544篇 |
26篇 | |
中国医学 | 4534篇 |
肿瘤学 | 3289篇 |
出版年
2024年 | 169篇 |
2023年 | 1074篇 |
2022年 | 1636篇 |
2021年 | 1991篇 |
2020年 | 1972篇 |
2019年 | 1886篇 |
2018年 | 1883篇 |
2017年 | 1747篇 |
2016年 | 1639篇 |
2015年 | 1460篇 |
2014年 | 3348篇 |
2013年 | 3338篇 |
2012年 | 2650篇 |
2011年 | 2819篇 |
2010年 | 2167篇 |
2009年 | 2067篇 |
2008年 | 2362篇 |
2007年 | 2392篇 |
2006年 | 2135篇 |
2005年 | 1794篇 |
2004年 | 1491篇 |
2003年 | 1394篇 |
2002年 | 1113篇 |
2001年 | 1022篇 |
2000年 | 822篇 |
1999年 | 714篇 |
1998年 | 513篇 |
1997年 | 540篇 |
1996年 | 414篇 |
1995年 | 424篇 |
1994年 | 370篇 |
1993年 | 312篇 |
1992年 | 311篇 |
1991年 | 274篇 |
1990年 | 229篇 |
1989年 | 213篇 |
1988年 | 204篇 |
1987年 | 160篇 |
1986年 | 126篇 |
1985年 | 129篇 |
1984年 | 139篇 |
1983年 | 89篇 |
1982年 | 89篇 |
1981年 | 98篇 |
1980年 | 85篇 |
1979年 | 55篇 |
1978年 | 55篇 |
1977年 | 37篇 |
1976年 | 40篇 |
1975年 | 33篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
22.
T.-Y. Huang Y.-J. Hsia M.-Y. Sung Y.-T. Wu P.-C. Hsu 《International journal of oral and maxillofacial surgery》2021,50(8):1100-1106
Zygomatic implant treatment is widely applied for severe maxillary atrophy to help rehabilitate the maxillary dentition. This retrospective study was performed to evaluate the actual radiographic bone–implant contact (rBIC) lengths of zygomatic implants. The records of 28 patients who underwent zygomatic implant surgery and subsequent follow-up examinations between August 2013 and September 2018 in the Department of Oral and Maxillofacial Surgery, Taipei Tzu Chi Hospital were reviewed. The surgeries were performed by a single surgeon using the same treatment protocol. All patients had a computed tomography scan at 1 year after the surgery. Using three-dimensional imaging software, an investigator measured the rBIC lengths of 66 implants and documented their clinical status. The implant survival rate was 100%. The mean rBIC length was significantly longer in male patients than in female patients (20.80 ± 5.88 mm versus 17.79 ± 6.34 mm; P = 0.028). The mean rBIC length of double zygomatic implants was significantly longer when compared to that of single implants (21.11 ± 6.23 mm versus 17.75 ± 5.85 mm; P = 0.027). This article is novel in reporting the exact rBIC lengths of zygomatic implants in a clinical setting. The results showed that zygomatic implants are a viable treatment modality for full-mouth rehabilitation. 相似文献
23.
24.
《Revue neurologique》2019,175(9):519-527
Background and purposeHospitals admitting acute strokes should offer access to mechanical thrombectomy (MT), but local organisations are still based on facilities available before MT was proven effective. MT rates and outcomes at population levels are needed to adapt organisations. We evaluated rates of MT and outcomes in inhabitants from the North-of-France (NoF) area.MethodWe prospectively evaluated rates of MT and outcomes of patients at 3 months, good outcomes being defined as a modified Rankin scale (mRS) 0 to 2 or like the pre-stroke mRS.ResultsDuring the study period (2016–2017), 666 patients underwent MT (454, 68.1% associated with intravenous thrombolysis [IVT]). Besides, 1595 other patients received IVT alone. The rate of MT was 81 (95% confidence interval [CI] 72–90) per million inhabitants-year, ranging from 36 to 108 between districts. The rate of IVT was 249 (95% CI 234–264) per million inhabitants-year, ranging from 155 to 268. After 3 months, 279 (41.9%) patients who underwent MT had good outcomes, and 167 (25.1%) had died. Patients living outside the district of Lille where the only MT centre is, were less likely to have good outcomes at 3 months, after adjustment on age, sex, baseline severity, and delay.ConclusionThe rate of MT is one of the highest reported up to now, even in low-rate districts, but outcomes were significantly worse in patients living outside the district of Lille, and this is not only explained by the delay. 相似文献
25.
26.
27.
28.
29.
目的 解析真实世界中乳腺恶性肿瘤患者的人群特征、诊断特征、中西医用药特征,为乳腺癌的临床防治提供参考。方法 采集2002年2月至2015年5月全国60家三级甲等医 院信息系统(Hospital Information System,HIS)中,出院诊断为“乳腺癌”的患者用药信息,采用SAS9.3统计软件,对人口学信息、诊断信息、医嘱用药信息等进行描述性分析。结果 39798例乳腺癌患者,平均年龄(50.93者,平均年龄)岁;多以门诊入院,入院病情以“一般”为主;合并疾病主要为高血压,骨肿瘤,联用西药以抑制肿瘤细胞增殖、治疗并发症、缓解放化疗不良反应为主;中医辨证以痰瘀互结证,气阴两虚证,肝气淤滞证,脾气亏虚证型最为常见,临床清热解毒剂、益气扶正剂,活血化瘀剂应用较多。结论 乳腺癌中西医结合治疗,联用药物广泛,临床治疗基本符合临床指南。 相似文献
30.
《Nutrition, metabolism, and cardiovascular diseases : NMCD》2020,30(10):1732-1741
AimsTo explore the association between WWI and the incidence of HTN in the Rural Chinese Cohort Study.Methods and ResultsWe examined data for 10,338 non-hypertensive participants (39.49% men) aged ≥ 18 years from the Rural Chinese Cohort Study who completed a baseline examination during 2007–2008 and follow-up during 2013–2014. WWI was calculated as waist circumference (cm) divided by the square root of weight (kg). Multiple logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for the probability of HTN across four WWI categories. Restricted cubic splines analysis was used to model the dose–response association of WWI and HTN. A total of 2078 participants had HTN during a median follow-up of 6 years. After adjusting for potential confounders, as compared with the lowest WWI category (<9.94 cm/√kg), with WWI 9.94 to 10.42, 10.42 to 10.91 and ≥ 10.91 cm/√kg, the ORs (95% CIs) for HTN were 1.12 (0.93–1.35), 1.40 (1.17–1.69) and 1.50 (1.24–1.82), respectively. Results of the sensitivity analyses were robust. The ORs were generally consistent on subgroup analysis by sex, smoking status, systolic blood pressure and diastolic blood pressure. Multiple logistic regression models with restricted cubic splines showed a non-linear positive association between WWI and HTN (Pnonlinearity < 0.001).ConclusionThe highest WWI category was significantly associated with increased risk of HTN. Our findings may facilitate the development and promotion of obesity prevention strategies aimed at reducing the risk of HTN and provide evidence for healthcare policy in rural China. 相似文献